CX 2021 Programme

The Hurting Leg: - Thursday, 22nd April
Venue:   Livestream 1
Time: 14:00 - 19:30
The hurting leg and COVID
Moderators:   Keith Harding, Cardiff, United Kingdom
Michael Edmonds, London, United Kingdom
The effect of COVID-19 on amputation rates across a twenty-nine hospital system
Speaker:   Alisha Oropallo, New York, United States
Opportunity from crisis: Reducing time to treatment for patients with critical limb ischaemia during the coronavirus pandemic
Speaker:   James Morris, Salford, United Kingdom
Clinical evaluation of CLTI patients and other frail patients in the era of COVID-19
Speaker:   Misti Malone, FDA, Silver Spring, United States
 
Networking break
Novel technology controversies
Moderators:   Thomas Zeller, Bad Krozingen, Germany
Gunnar Tepe, Rosenheim, Germany
Amputation-free survival and limb salvage with deep venous arterialisation
Speaker:   Peter Schneider, San Francisco, United States
The impact of socio-economic and clinical variables on the incidence of major amputation in people with diabetic foot ulcers
Speaker:   William Jeffcoate, Nottingham, United Kingdom
Results of the PRELUDE-BTK study: Novel serration angioplasty balloon for the below-the-knee arteries
Speaker:   Andrew Holden, Auckland, New Zealand
CX Debate: Paclitaxel-coated balloon should be treatment of choice for preventing restenosis in below-the-knee interventions

For the motion
Francesco Liistro, Arezzo, Italy

Against the motion
Robert Hinchliffe, Bristol, United Kingdom

 
The hurting leg controversies
Moderators:   Andrew Holden, Auckland, New Zealand
Robert Hinchliffe, Bristol, United Kingdom
Chronic limb-threatening ischaemia: Options for treatment - open surgery vein and grafts
Speaker:   Richard Neville, San Francisco, United States
Podium 1st: Five-year outcomes of DCB treatment in critical limb ischaemia from the IN.PACT Global Study
Speaker:   Michel Reijnen, Arnhem, Netherlands
Catheter-directed thrombolysis versus aspiration thrombectomy in the management of acute limb ischaemia - lessons learned from a multicentre retrospective physician-initiated registry
Speaker:   Maria Antonella Ruffino, Turin, Italy
Prediction model for freedom from TLR from a multi-study analysis of long-term results with a drug-eluting stent
Speaker:   Michael Dake, Tucson, United States
Budget impact analysis of heparin-bonded ePTFE grafts against standard ePTFE grafts for below-the-knee bypass in patients with critical limb ischaemia
Speaker:   Yann Goueffic, Nantes, France
Experience and long-term outcomes with infrapopliteal drug-eluting stents in patients with critical limb ischaemia
Speaker:   Claudia Riera, Barcelona, Spain
 
Networking break
Intervention considerations controversies
Moderators:   Thomas Zeller, Bad Krozingen, Germany
Andrew Holden, Auckland, New Zealand
Impact of chronic kidney disease on the outcomes of infrapopliteal venous and heparin-bonded expanded polytetrafluoroethylene bypass surgeries
Speaker:   Markus Steinbauer, President DGG, Regensburg, Germany
PRESTIGE Trial: Multicentre trial analysing IVUS-guided atherectomy below-the-knee in patients with critical limb ischaemia
Speaker:   Michael Lichtenberg, Arnsberg, Germany
Functional outcome after major limb amputation in vascular surgery
Speaker:   Arsalan Wafi, Southall, United Kingdom
 
Roundtable: Unacceptable high major amputation rate - urgent advance needed
The diabetologist's perspective
Speaker:   Michael Edmonds, London, United Kingdom
The vascular surgeon's perspective
Speaker:   Robert Hinchliffe, Bristol, United Kingdom
The interventional radiologist's perspective
Speaker:   Gunnar Tepe, Rosenheim, Germany